Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01623856 · ClinicalTrials.gov registry record
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 483
- Enrollment target
NCT01623856: Completed study, sponsored by Children's Oncology Group.
NCT01623856 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 483 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01623856 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 483 participants
- Enrollment target
Study Summary
This research studies genes associated with non-Hodgkin lymphoma in young patients. Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-06 |
What the finished NCT01623856 record still lists
NCT01623856 is an observational study that tracks outcomes without assigning an intervention. The registered 483 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01623856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01623856 about?
NCT01623856 is a clinical study titled "Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients". This research studies genes associated with non-Hodgkin lymphoma in young patients. Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
What is the current status of trial NCT01623856?
This trial is currently completed. The enrollment target is 483 participants. The study started on 2012-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01623856?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01623856?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia